Artificial intelligence (AI) has found a regular place in clinical trials, from recruitment to anaysis – but are the regulators keeping up?
This month’s cover feature examines the realities of the technology appearing far ahead of regulation, and examines what the regulators are planning in response.
Go deeper with GlobalData
Also in this issue, we examine what newborn screening protocols may emerge in the US since the disbandment of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), a federally appointed body under the US Health Resources and Services Administration (HRSA), in April. Don’t miss our analyst comments on several intiguing poster session from the 2025 American Thoracic Society (ATS) International Conference.
All this and the latest pharma industry news, comment, and analysis from GlobalData.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
